๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Participants With Advanced Solid Tumor Malignancies

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration NCT07718165Phase 11 site๐Ÿ“ Shanghai Abbisko Therapeutics Co, Ltd ยท Tests: ABSK211 A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ New Haven Pfizer ยท Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site๐Ÿ“ Shanghai Hansoh BioMedical R&D Company ยท Tests: HS-20108 Monotherapy A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010) NCT07785609Phase 24 sites๐Ÿ“ San Antonio๐Ÿ“ Hong Kong๐Ÿ“ Bellinzona Merck Sharp & Dohme LLC ยท Tests: MK-2010, Sacituzumab tirumotecan, Histamine H1 Receptor Antagonist, Histamine H2 Receptor Antagonist, Acetaminophen (orโ€ฆ A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors NCT06716138Phase 15 sites๐Ÿ“ New York๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou Avistone Biotechnology Co., Ltd. ยท Tests: ANS03 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors NCT05836324Phase 139 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Boston Incyte Corporation ยท Tests: INCA33890, bevacizumab, FOLFIRI, FOLFOX, Cetuximab A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies NCT06994806Phase 115 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Denver Kumquat Biosciences Inc. ยท Tests: KQB168, Pembrolizumab Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors NCT07387068Phase 112 sites๐Ÿ“ New Haven๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success Genmab ยท Tests: GEN1079 Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors NCT07644650Phase 11 site๐Ÿ“ Shanghai Mabsoft Therapeutics (Shanghai) Co., Ltd. ยท Tests: MST-168 Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors NCT06598800Phase 134 sites๐Ÿ“ Hackensack๐Ÿ“ Houston๐Ÿ“ Fairfax BeOne Medicines ยท Tests: Drug: BG-T187, Other Therapeutic Agents Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites๐Ÿ“ New Haven๐Ÿ“ Huntersville๐Ÿ“ Galveston EMD Serono Research & Development Institute, Inc. ยท Tests: M7437, M7437 Safety and Efficacy of OBX-115 in Advanced Solid Tumors NCT06060613Phase 1, Phase 210 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Stanford Obsidian Therapeutics, Inc. ยท Tests: OBX-115 Study of FID-022 in Participants With Advanced Solid Tumors NCT06694480Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Tampa Fulgent Pharma LLC. ยท Tests: FID-022 A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Grand Rapids๐Ÿ“ Long Island City Pfizer ยท Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD) NCT06551142Phase 167 sites๐Ÿ“ Stanford๐Ÿ“ Denver๐Ÿ“ New Haven GlaxoSmithKline ยท Tests: Ris-Rez, Cisplatin, Carboplatin, Atezolizumab, Pembrolizumab A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Atlanta Amgen ยท Tests: AMG 410, Pembrolizumab, Panitumumab IKS014 in Advanced Solid Tumors That Express HER2 NCT05872295Phase 113 sites๐Ÿ“ Newport Beach๐Ÿ“ Boston๐Ÿ“ Nashville Iksuda Therapeutics Ltd. ยท Tests: IKS014 QLS5212 for Participants With Advanced Solid Tumors NCT07467629Phase 11 site๐Ÿ“ Taiyuan Qilu Pharmaceutical Co., Ltd. ยท Tests: QLS5212 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) NCT03486873Phase 3782 sites๐Ÿ“ Tucson๐Ÿ“ Bakersfield๐Ÿ“ Fresno Merck Sharp & Dohme LLC ยท Tests: Pembrolizumab, Standard of Care (SOC), Lenvatinib, Olaparib, MK-4280 A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors NCT07300150Phase 19 sites๐Ÿ“ Boston๐Ÿ“ San Antonio๐Ÿ“ San Antonio PAQ Therapeutics, Inc. ยท Tests: PT0511, Cetuximab A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors NCT07123103Phase 19 sites๐Ÿ“ Rogers๐Ÿ“ Los Angeles๐Ÿ“ Washington D.C. Exelixis ยท Tests: XB371 A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Bristol-Myers Squibb ยท Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors NCT04777994Phase 130 sites๐Ÿ“ Tucson๐Ÿ“ New Haven๐Ÿ“ Baltimore Calico Life Sciences LLC ยท Tests: ABBV-CLS-484, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI), Programmed Cell Deatโ€ฆ A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors NCT05765851Phase 115 sites๐Ÿ“ Sarasota๐Ÿ“ New York๐Ÿ“ Providence Daiichi Sankyo ยท Tests: DS-1103a, T-DXd A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites๐Ÿ“ Los Angeles๐Ÿ“ Dallas๐Ÿ“ Houston Pilatus Biosciences Inc ยท Tests: PLT012 A Study of PYX-201 in Advanced Solid Tumors NCT05720117Phase 129 sites๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles๐Ÿ“ Denver Pyxis Oncology, Inc ยท Tests: PYX-201 Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors NCT06963281Phase 19 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Fortvita Biologics (USA)Inc. ยท Tests: IBI3020
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy